Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cohort Study of the Combination Regimen Based on Rolapitant and Palonosetron for the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy in Lung Cancer Patients

NCT07442890 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT07442890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07442890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cohort Study of the Combination Regimen Based on Rolapitant and Palonosetron for the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy in Lung Cancer Patients
Lead sponsor
Henan Cancer Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
June 30, 2028
Enrollment
238 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer